SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-18-138875
Filing Date
2018-04-27
Accepted
2018-04-27 16:10:56
Documents
7
Effectiveness Date
2018-04-27

Document Format Files

Seq Description Document Type Size
1 DEFA14A d519919ddefa14a.htm DEFA14A 47299
2 GRAPHIC g519919logo.jpg GRAPHIC 5197
3 GRAPHIC g519919n2.jpg GRAPHIC 3962
4 GRAPHIC g519919naa1.jpg GRAPHIC 900
5 GRAPHIC g519919naa2.jpg GRAPHIC 896
6 GRAPHIC g519919naa3.jpg GRAPHIC 890
7 GRAPHIC g519919naa4.jpg GRAPHIC 904
  Complete submission text file 0001193125-18-138875.txt   66874
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

IRS No.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-19311 | Film No.: 18783960
SIC: 2836 Biological Products, (No Diagnostic Substances)